Revance Therapeutics Inc (RVNC)

[IanFromSI]

Vinman, RVNC is going up, against a very experienced, very professional, established salesforce. They have faced competitors before and fared very well.

I wouldn’t be surprised to see RVNC in the $10-$12 range again. To the extent that its salesforce is able to deliver product to end customers and the end customers see the significant advantages that due diligence does, substantial price gains above the 30s are definitely possible.

At this time, there’s still uncertainty.

JMHO

Ian.